Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04053855

Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Clear cell renal cell carcinoma is diagnosed by imaging, sometimes associated with biopsy. This diagnosis is expensive, invasive and sometimes late. The development of a simple biological test for diagnosis is essential. Exosomes are 30 to 150 nm membrane vesicles secreted into the extracellular space by various living cells. These exosomes can be isolated from biological fluids, including urine. The recent study of urinary exosomes is a promising topic for analyzing tumor markers in urine. The investigator's goal is to develop a reliable technique for detecting tumor exosomes in urine in patients with clear cell renal cell carcinoma. The analysis of urinary exosomes could provide a new liquid biopsy tool for the early diagnosis of clear cell renal cell carcinoma.

Detailed description

The primary objective is to detect urinary exosomes, by electron microscopy technique, from clear cell renal cell carcinoma due to exosome markers (CD9) and clear cell kidney cancer (CA9).

Conditions

Interventions

TypeNameDescription
BIOLOGICALUrinary sampleUrinary sample (100 ml) will be collected in the urology department to analysis urinary exosomes.

Timeline

Start date
2020-01-29
Primary completion
2026-08-01
Completion
2026-08-01
First posted
2019-08-13
Last updated
2024-10-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04053855. Inclusion in this directory is not an endorsement.

Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma (NCT04053855) · Clinical Trials Directory